Latest news
Sanofi rated Buy with 33.5% upside, driven by D... - PluangPluang · Thu, 06 Aug 2026 10:57:05 GMTDupixent Lawsuit for T-Cell Lymphoma - Lawsuit Information CenterLawsuit Information Center · Wed, 05 Aug 2026 14:17:30 GMTDupixent Lawsuit Alleges Failure to Warn of Cancer Risk - LawyersandSettlements.comLawyersandSettlements.com · Thu, 30 Jul 2026 08:00:00 GMT